Company news: AstraZeneca and Merck

Share this article:

AstraZeneca launched a home-delivery program for breast cancer drug Arimidex through PBM Express Scripts. AZ spokesperson Anna Padula told MM&M that generics pushed Arimidex off of many formularies in 2010 and that the program was spurred by patients who, forced to pay for Arimidex out of pocket, entreated the company for a lower price point. The home-delivery program will charge $40 for a 30-day supply, $120 for 90 days. It is the company's first direct-to-patient prescription program.

Grammy-winner Jon Secada is joining Merck's “Tune into Hep C” awareness program. The bilingual campaign is aimed at raising awareness among Hispanics, who comprise about one-third of the Americans who have the hepatitis C virus. Performers Gregg Allman and Natalie Cole are also part of the awareness campaign which Merck and the American Liver Foundation launched last year. Secada said his father, recently deceased, hid his own HCV diagnosis for a decade but eventually urged his son to “share his story to help other people like him who have chronic hepatitis C but aren't taking action.” Secada's story is featured on the site HepatitisCtocaElTema.com.

Share this article:

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.